Equaline Lansoprazole Capsule, Delayed Release
Product Images NDC 41163-150

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Equaline Lansoprazole (NDC 41163-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by United Natural Foods, Inc. Dba Unfi, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Image 1 (Image 01)

Box and bottle label for Equaline lansoprazole 15 mg delayed-release capsules. The packaging indicates 14 capsules per bottle, intended for a 14-day course of treatment. The label highlights it as an acid reducer and compares the active ingredient to Prevacid 24 HR. Distributed by United Natural Foods, Inc. in Providence, RI. The bottle and capsule image are shown at actual size.*

FDA Label Image

Lansoprazole Image 2 (Image 02)

Drug Facts text panels for equaline lansoprazole 15 mg delayed-release capsules detail active ingredient, use, warnings, directions, other information, inactive ingredients, and questions or comments contact. They include dosage guidance for adults, warnings about allergies, conditions requiring doctor consultation, and storage instructions. The label emphasizes reading the carton and package insert.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.